WASHINGTON, D.C. – In the wake of ongoing shortages of essential medications, Rep. Earl L. “Buddy” Carter (R-GA) today led a letter to Department of Health and Human Services (HHS) Secretary Xavier Becerra calling on the department to prioritize American-made pharmaceuticals in the U.S. Strategic National Stockpile (SNS).
In the letter, the members write: "Our SNS is far too… Read more »
WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA) and Chrissy Houlahan (D-PA) introduced the State Strategic Stockpile Act, a bill to extend the authorization of and funding for a program supporting states in developing and maintaining stockpiles of critical drugs, vaccines, and other medical supplies in case of a public health emergency or supply chain disruption.
Currently, the… Read more »
WASHINGTON, D.C. - Pharmacy Benefit Managers (PBMs) are the pharmaceutical supply chain's hidden middlemen that are driving up costs for prescription medications, delaying access to necessary treatments, and robbing hope from patients. It's time we pull back the curtain on these insidious actors.
Today, the House Committee on Oversight and Accountability will host its first ever… Read more »
WASHINGTON, D.C. – Following Rite Aid, Walgreens, and CVS Pharmacy announcing that they plan to become certified to dispense the chemical abortion drug mifepristone, Reps. Earl L. “Buddy” Carter (R-GA) and Chris Smith (R-NJ) led 36 House Republicans in a letter calling on the companies to protect the health and safety of women and unborn children.
In the letter, the members write: “We… Read more »
WASHINGTON, D.C. - Reps. Earl L. "Buddy" Carter (R-GA), Lisa Blunt Rochester (D-DE), Nicole Malliotakis (R-NY), and Jake Auchincloss (D-MA) introduced the Protecting Patients Against PBM Abuses Act to protect patients and pharmacies from harmful pharmacy benefit manager (PBM) practices that make high-quality health care inaccessible and unaffordable.
The bill… Read more »
BRUNSWICK, GA – In recognition of National Crime Victims’ Rights Week (NCVRW), Rep. Earl L. “Buddy” Carter (R-GA), a pharmacist by trade, on Monday distributed drug safety pocket cards to local schools and called for the Department of Justice’s (DOJ) Office for Victims of Crime (OVC) to provide survivor resources to the families of victims of illicit fentanyl poisoning.
… Read more »
WASHINGTON, D.C. – Reps. Earl L. "Buddy" Carter (R-GA), Darren Soto (D-FL), Carol Miller (R-WV), and Matt Cartwright (D-PA) today reintroduced a bill to make the U.S. pharmaceutical supply chain less dependent on China and other foreign adversaries.
According to the Food and Drug Administration, approximately 72 percent of active pharmaceutical ingredients (API) used in the U.S. drug… Read more »
ATLANTA, GA -- The 2023 Rx and Illicit Drug Summit featured a congressional panel on day two of the 12th annual conference led by U.S. Rep. Hal Rogers (KY-05), Dean of the House, who launched the national summit to help combat America's deadly epidemic. Congressman Rogers was joined by Reps. Earl L. "Buddy" Carter (R-GA), David Trone (D-MD), Matt Cartwright (D-PA), and Andrew Clyde… Read more »
WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA), Henry Cuellar (D-TX), and Chairman of the Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party Mike Gallagher (R-WI) today introduced the bipartisan Pausing Enhanced Pandemic Pathogen Research Act to ban taxpayer dollars from funding gain-of-function research for five years, allowing… Read more »
WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) successfully lobbied the Food and Drug Administration (FDA) today to increase access to Emergent Biosolution’s life-saving opioid overdose reversal nasal spray, sold under the brand name Narcan, for use without a prescription.
Naloxone nasal spray is a safe, easy to use treatment that is proven “to reduce medical emergencies, drug… Read more »
